Regeneron Pharmaceuticals (REGN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 1,115,200 | 3,513,200 | 2,364,000 | 1,521,900 | 624,600 |
| Depreciation Amortization | 67,400 | 235,900 | 174,200 | 114,900 | 56,100 |
| Income taxes - deferred | 10,100 | 75,600 | 117,900 | 118,000 | 9,900 |
| Accounts receivable | -58,300 | -1,356,100 | -1,275,300 | -47,100 | -169,000 |
| Other Working Capital | -539,400 | -1,503,600 | -1,468,200 | -146,900 | -181,000 |
| Other Operating Activity | 73,500 | 1,653,100 | 1,474,500 | 80,600 | 357,400 |
| Operating Cash Flow | $668,500 | $2,618,100 | $1,387,100 | $1,641,400 | $698,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -943,700 | 544,000 | 687,600 | 1,310,200 | -273,100 |
| PPE Investments | -115,300 | -614,600 | -453,200 | -300,000 | -170,100 |
| Investing Cash Flow | $-1,059,000 | $-70,600 | $234,400 | $1,010,200 | $-443,200 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 1,500,000 | 1,500,000 | 1,500,000 | N/A |
| Debt Issued | N/A | 1,981,900 | 1,981,900 | N/A | N/A |
| Common Stock Issued | 95,000 | 2,575,200 | 2,471,100 | 2,168,000 | 811,400 |
| Common Stock Repurchased | -461,400 | -6,527,600 | -6,118,200 | -5,945,200 | -475,800 |
| Other Financing Activity | 0 | -1,500,000 | -1,500,000 | 0 | 0 |
| Financing Cash Flow | $-366,400 | $-1,970,500 | $-1,665,200 | $-2,277,200 | $335,600 |
| Beginning Cash Position | 2,207,300 | 1,630,300 | 1,630,300 | 1,630,300 | 1,630,300 |
| End Cash Position | 1,450,400 | 2,207,300 | 1,586,600 | 2,004,700 | 2,220,700 |
| Net Cash Flow | $-756,900 | $577,000 | $-43,700 | $374,400 | $590,400 |
| Free Cash Flow | |||||
| Operating Cash Flow | 668,500 | 2,618,100 | 1,387,100 | 1,641,400 | 698,000 |
| Capital Expenditure | -115,300 | -614,600 | -453,200 | -300,000 | -170,100 |
| Free Cash Flow | 553,200 | 2,003,500 | 933,900 | 1,341,400 | 527,900 |